Dementia Discovery LP
SV Health Investors · adviser of record: SV Life Sciences Advisers, LLC · 2015 vintage
Dementia Discovery LP is a 2015 venture fund managed by SV Health Investors. It reported $170mm in gross assets at year-end 2017, its highest reported value.
- Latest value held
- $170mm year-end 2017
- Peak
- $170mm year-end 2017
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2017 | $170mm | – | +69% |
| 2016 | $100mm | – | -3% |
| 2015 | $103mm | – | – |
Other funds from SV Health Investors
- SV7 Growth Fund Strategic Partners, L.P. 2022
- SV Life Sciences Fund IV CF, L.P. 2021
- SV7 Growth Fund, L.P. 2018
- Medtech Convergence Fund, L.P. 2018
- SV Life Sciences Fund VI Strategic Partners, L.P. 2016
- SV Life Sciences Fund VI, L.P. 2015
- SV Life Sciences Fund IV, L.P. 2011
- SV Life Sciences Fund V, L.P. 2011
- International Life Sciences Fund III (LP1), L.P. 2011
- Schroder Ventures International Life Sciences Fund II L.P.1 2011
- SV Life Sciences Fund IV Strategic Partners, L.P. 2011
- SV Life Sciences Fund V Strategic Partners, L.P. 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-6870357172. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.